nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP2D6—Hydroxyurea—head and neck cancer	0.274	0.449	CbGbCtD
Rotigotine—CYP1A2—Fluorouracil—head and neck cancer	0.127	0.208	CbGbCtD
Rotigotine—CYP2D6—Vinblastine—head and neck cancer	0.0968	0.159	CbGbCtD
Rotigotine—CYP3A4—Vinblastine—head and neck cancer	0.0616	0.101	CbGbCtD
Rotigotine—CYP3A4—Docetaxel—head and neck cancer	0.0508	0.0833	CbGbCtD
Rotigotine—Papule—Hydroxyurea—head and neck cancer	0.0313	0.0822	CcSEcCtD
Rotigotine—Dysaesthesia—Fluorouracil—head and neck cancer	0.0114	0.0299	CcSEcCtD
Rotigotine—Balance disorder—Fluorouracil—head and neck cancer	0.009	0.0236	CcSEcCtD
Rotigotine—Dysaesthesia—Docetaxel—head and neck cancer	0.00821	0.0215	CcSEcCtD
Rotigotine—Prurigo—Docetaxel—head and neck cancer	0.00769	0.0202	CcSEcCtD
Rotigotine—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00653	0.0171	CcSEcCtD
Rotigotine—Disorientation—Hydroxyurea—head and neck cancer	0.00555	0.0146	CcSEcCtD
Rotigotine—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.00526	0.0138	CcSEcCtD
Rotigotine—Laryngeal pain—Docetaxel—head and neck cancer	0.00521	0.0137	CcSEcCtD
Rotigotine—Haemoglobin decreased—Docetaxel—head and neck cancer	0.00516	0.0135	CcSEcCtD
Rotigotine—Inflammation—Fluorouracil—head and neck cancer	0.00507	0.0133	CcSEcCtD
Rotigotine—Breast disorder—Hydroxyurea—head and neck cancer	0.00448	0.0118	CcSEcCtD
Rotigotine—Depression—Vinblastine—head and neck cancer	0.00418	0.011	CcSEcCtD
Rotigotine—Swelling—Fluorouracil—head and neck cancer	0.00405	0.0106	CcSEcCtD
Rotigotine—Disorientation—Fluorouracil—head and neck cancer	0.00399	0.0105	CcSEcCtD
Rotigotine—Weight increased—Hydroxyurea—head and neck cancer	0.0039	0.0102	CcSEcCtD
Rotigotine—Infestation—Hydroxyurea—head and neck cancer	0.00382	0.01	CcSEcCtD
Rotigotine—Infestation NOS—Hydroxyurea—head and neck cancer	0.00382	0.01	CcSEcCtD
Rotigotine—Inflammation—Docetaxel—head and neck cancer	0.00366	0.00961	CcSEcCtD
Rotigotine—Lethargy—Fluorouracil—head and neck cancer	0.00364	0.00956	CcSEcCtD
Rotigotine—Hallucination—Hydroxyurea—head and neck cancer	0.00342	0.00896	CcSEcCtD
Rotigotine—Irritability—Fluorouracil—head and neck cancer	0.00341	0.00895	CcSEcCtD
Rotigotine—Skin exfoliation—Docetaxel—head and neck cancer	0.00339	0.0089	CcSEcCtD
Rotigotine—Fluid retention—Docetaxel—head and neck cancer	0.00337	0.00885	CcSEcCtD
Rotigotine—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00319	0.00838	CcSEcCtD
Rotigotine—Angiopathy—Hydroxyurea—head and neck cancer	0.00311	0.00817	CcSEcCtD
Rotigotine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00304	0.00798	CcSEcCtD
Rotigotine—Erythema—Hydroxyurea—head and neck cancer	0.00299	0.00784	CcSEcCtD
Rotigotine—Malaise—Vinblastine—head and neck cancer	0.00295	0.00775	CcSEcCtD
Rotigotine—Vertigo—Vinblastine—head and neck cancer	0.00294	0.00773	CcSEcCtD
Rotigotine—Swelling—Docetaxel—head and neck cancer	0.00292	0.00767	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00287	0.00753	CcSEcCtD
Rotigotine—Hypertension—Vinblastine—head and neck cancer	0.00283	0.00742	CcSEcCtD
Rotigotine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00277	0.00728	CcSEcCtD
Rotigotine—Discomfort—Vinblastine—head and neck cancer	0.00276	0.00723	CcSEcCtD
Rotigotine—Hot flush—Docetaxel—head and neck cancer	0.00276	0.00723	CcSEcCtD
Rotigotine—Infestation NOS—Fluorouracil—head and neck cancer	0.00275	0.00722	CcSEcCtD
Rotigotine—Infestation—Fluorouracil—head and neck cancer	0.00275	0.00722	CcSEcCtD
Rotigotine—Menopausal symptoms—Docetaxel—head and neck cancer	0.00273	0.00717	CcSEcCtD
Rotigotine—Malaise—Hydroxyurea—head and neck cancer	0.00269	0.00707	CcSEcCtD
Rotigotine—Lethargy—Docetaxel—head and neck cancer	0.00263	0.0069	CcSEcCtD
Rotigotine—Sinusitis—Fluorouracil—head and neck cancer	0.00258	0.00678	CcSEcCtD
Rotigotine—Anorexia—Vinblastine—head and neck cancer	0.00255	0.00669	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00253	0.00663	CcSEcCtD
Rotigotine—Discomfort—Hydroxyurea—head and neck cancer	0.00251	0.0066	CcSEcCtD
Rotigotine—Infection—Hydroxyurea—head and neck cancer	0.00242	0.00636	CcSEcCtD
Rotigotine—Paraesthesia—Vinblastine—head and neck cancer	0.0024	0.0063	CcSEcCtD
Rotigotine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00239	0.00628	CcSEcCtD
Rotigotine—Skin disorder—Hydroxyurea—head and neck cancer	0.00237	0.00622	CcSEcCtD
Rotigotine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00235	0.00618	CcSEcCtD
Rotigotine—Breast disorder—Docetaxel—head and neck cancer	0.00233	0.00611	CcSEcCtD
Rotigotine—Anorexia—Hydroxyurea—head and neck cancer	0.00232	0.0061	CcSEcCtD
Rotigotine—Decreased appetite—Vinblastine—head and neck cancer	0.00232	0.0061	CcSEcCtD
Rotigotine—Nasopharyngitis—Docetaxel—head and neck cancer	0.0023	0.00605	CcSEcCtD
Rotigotine—Constipation—Vinblastine—head and neck cancer	0.00229	0.006	CcSEcCtD
Rotigotine—Pain—Vinblastine—head and neck cancer	0.00229	0.006	CcSEcCtD
Rotigotine—Feeling abnormal—Vinblastine—head and neck cancer	0.0022	0.00578	CcSEcCtD
Rotigotine—Somnolence—Hydroxyurea—head and neck cancer	0.00217	0.00569	CcSEcCtD
Rotigotine—Erythema—Fluorouracil—head and neck cancer	0.00215	0.00564	CcSEcCtD
Rotigotine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00215	0.00563	CcSEcCtD
Rotigotine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00212	0.00556	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00211	0.00553	CcSEcCtD
Rotigotine—Fatigue—Hydroxyurea—head and neck cancer	0.0021	0.00552	CcSEcCtD
Rotigotine—Pain—Hydroxyurea—head and neck cancer	0.00209	0.00547	CcSEcCtD
Rotigotine—Constipation—Hydroxyurea—head and neck cancer	0.00209	0.00547	CcSEcCtD
Rotigotine—Weight increased—Docetaxel—head and neck cancer	0.00203	0.00532	CcSEcCtD
Rotigotine—Weight decreased—Docetaxel—head and neck cancer	0.00202	0.00529	CcSEcCtD
Rotigotine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00201	0.00527	CcSEcCtD
Rotigotine—Infestation—Docetaxel—head and neck cancer	0.00199	0.00521	CcSEcCtD
Rotigotine—Infestation NOS—Docetaxel—head and neck cancer	0.00199	0.00521	CcSEcCtD
Rotigotine—Hypersensitivity—Vinblastine—head and neck cancer	0.00197	0.00517	CcSEcCtD
Rotigotine—Asthenia—Vinblastine—head and neck cancer	0.00192	0.00503	CcSEcCtD
Rotigotine—Diarrhoea—Vinblastine—head and neck cancer	0.00183	0.0048	CcSEcCtD
Rotigotine—Discomfort—Fluorouracil—head and neck cancer	0.00181	0.00475	CcSEcCtD
Rotigotine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.0018	0.00472	CcSEcCtD
Rotigotine—Confusional state—Fluorouracil—head and neck cancer	0.00177	0.00464	CcSEcCtD
Rotigotine—Dizziness—Vinblastine—head and neck cancer	0.00177	0.00464	CcSEcCtD
Rotigotine—Oedema peripheral—Docetaxel—head and neck cancer	0.00176	0.00461	CcSEcCtD
Rotigotine—Connective tissue disorder—Docetaxel—head and neck cancer	0.00175	0.0046	CcSEcCtD
Rotigotine—Asthenia—Hydroxyurea—head and neck cancer	0.00175	0.00459	CcSEcCtD
Rotigotine—Infection—Fluorouracil—head and neck cancer	0.00174	0.00458	CcSEcCtD
Rotigotine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00172	0.00452	CcSEcCtD
Rotigotine—Visual impairment—Docetaxel—head and neck cancer	0.00172	0.00451	CcSEcCtD
Rotigotine—Vomiting—Vinblastine—head and neck cancer	0.0017	0.00446	CcSEcCtD
Rotigotine—Headache—Vinblastine—head and neck cancer	0.00168	0.0044	CcSEcCtD
Rotigotine—Anorexia—Fluorouracil—head and neck cancer	0.00167	0.00439	CcSEcCtD
Rotigotine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00167	0.00438	CcSEcCtD
Rotigotine—Hypotension—Fluorouracil—head and neck cancer	0.00164	0.0043	CcSEcCtD
Rotigotine—Angiopathy—Docetaxel—head and neck cancer	0.00162	0.00425	CcSEcCtD
Rotigotine—Dizziness—Hydroxyurea—head and neck cancer	0.00161	0.00423	CcSEcCtD
Rotigotine—Immune system disorder—Docetaxel—head and neck cancer	0.00161	0.00423	CcSEcCtD
Rotigotine—Mediastinal disorder—Docetaxel—head and neck cancer	0.00161	0.00422	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.0016	0.0042	CcSEcCtD
Rotigotine—Nausea—Vinblastine—head and neck cancer	0.00159	0.00417	CcSEcCtD
Rotigotine—Insomnia—Fluorouracil—head and neck cancer	0.00159	0.00417	CcSEcCtD
Rotigotine—Paraesthesia—Fluorouracil—head and neck cancer	0.00158	0.00414	CcSEcCtD
Rotigotine—Mental disorder—Docetaxel—head and neck cancer	0.00156	0.0041	CcSEcCtD
Rotigotine—Somnolence—Fluorouracil—head and neck cancer	0.00156	0.0041	CcSEcCtD
Rotigotine—Erythema—Docetaxel—head and neck cancer	0.00155	0.00407	CcSEcCtD
Rotigotine—Malnutrition—Docetaxel—head and neck cancer	0.00155	0.00407	CcSEcCtD
Rotigotine—Vomiting—Hydroxyurea—head and neck cancer	0.00155	0.00407	CcSEcCtD
Rotigotine—Dyspepsia—Fluorouracil—head and neck cancer	0.00155	0.00405	CcSEcCtD
Rotigotine—Rash—Hydroxyurea—head and neck cancer	0.00154	0.00404	CcSEcCtD
Rotigotine—Dermatitis—Hydroxyurea—head and neck cancer	0.00154	0.00403	CcSEcCtD
Rotigotine—Headache—Hydroxyurea—head and neck cancer	0.00153	0.00401	CcSEcCtD
Rotigotine—Decreased appetite—Fluorouracil—head and neck cancer	0.00153	0.004	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00152	0.00398	CcSEcCtD
Rotigotine—Pain—Fluorouracil—head and neck cancer	0.0015	0.00394	CcSEcCtD
Rotigotine—Muscle spasms—Docetaxel—head and neck cancer	0.00149	0.00392	CcSEcCtD
Rotigotine—Nausea—Hydroxyurea—head and neck cancer	0.00145	0.0038	CcSEcCtD
Rotigotine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00145	0.0038	CcSEcCtD
Rotigotine—Urticaria—Fluorouracil—head and neck cancer	0.00139	0.00366	CcSEcCtD
Rotigotine—Syncope—Docetaxel—head and neck cancer	0.00139	0.00365	CcSEcCtD
Rotigotine—Loss of consciousness—Docetaxel—head and neck cancer	0.00136	0.00358	CcSEcCtD
Rotigotine—Cough—Docetaxel—head and neck cancer	0.00135	0.00355	CcSEcCtD
Rotigotine—Hypertension—Docetaxel—head and neck cancer	0.00134	0.00352	CcSEcCtD
Rotigotine—Arthralgia—Docetaxel—head and neck cancer	0.00132	0.00347	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00131	0.00344	CcSEcCtD
Rotigotine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00129	0.00339	CcSEcCtD
Rotigotine—Dry mouth—Docetaxel—head and neck cancer	0.00129	0.00339	CcSEcCtD
Rotigotine—Confusional state—Docetaxel—head and neck cancer	0.00128	0.00335	CcSEcCtD
Rotigotine—Infection—Docetaxel—head and neck cancer	0.00126	0.0033	CcSEcCtD
Rotigotine—Shock—Docetaxel—head and neck cancer	0.00125	0.00327	CcSEcCtD
Rotigotine—Nervous system disorder—Docetaxel—head and neck cancer	0.00124	0.00326	CcSEcCtD
Rotigotine—Pruritus—Fluorouracil—head and neck cancer	0.00124	0.00326	CcSEcCtD
Rotigotine—Skin disorder—Docetaxel—head and neck cancer	0.00123	0.00323	CcSEcCtD
Rotigotine—Anorexia—Docetaxel—head and neck cancer	0.00121	0.00317	CcSEcCtD
Rotigotine—Diarrhoea—Fluorouracil—head and neck cancer	0.0012	0.00315	CcSEcCtD
Rotigotine—Hypotension—Docetaxel—head and neck cancer	0.00118	0.00311	CcSEcCtD
Rotigotine—Dizziness—Fluorouracil—head and neck cancer	0.00116	0.00305	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00115	0.00303	CcSEcCtD
Rotigotine—Insomnia—Docetaxel—head and neck cancer	0.00115	0.00301	CcSEcCtD
Rotigotine—Paraesthesia—Docetaxel—head and neck cancer	0.00114	0.00299	CcSEcCtD
Rotigotine—Somnolence—Docetaxel—head and neck cancer	0.00113	0.00296	CcSEcCtD
Rotigotine—Vomiting—Fluorouracil—head and neck cancer	0.00112	0.00293	CcSEcCtD
Rotigotine—Dyspepsia—Docetaxel—head and neck cancer	0.00112	0.00293	CcSEcCtD
Rotigotine—Rash—Fluorouracil—head and neck cancer	0.00111	0.0029	CcSEcCtD
Rotigotine—Dermatitis—Fluorouracil—head and neck cancer	0.00111	0.0029	CcSEcCtD
Rotigotine—Decreased appetite—Docetaxel—head and neck cancer	0.0011	0.00289	CcSEcCtD
Rotigotine—Headache—Fluorouracil—head and neck cancer	0.0011	0.00289	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00109	0.00287	CcSEcCtD
Rotigotine—Fatigue—Docetaxel—head and neck cancer	0.00109	0.00287	CcSEcCtD
Rotigotine—Pain—Docetaxel—head and neck cancer	0.00108	0.00284	CcSEcCtD
Rotigotine—Constipation—Docetaxel—head and neck cancer	0.00108	0.00284	CcSEcCtD
Rotigotine—Feeling abnormal—Docetaxel—head and neck cancer	0.00104	0.00274	CcSEcCtD
Rotigotine—Nausea—Fluorouracil—head and neck cancer	0.00104	0.00274	CcSEcCtD
Rotigotine—Hypersensitivity—Docetaxel—head and neck cancer	0.000933	0.00245	CcSEcCtD
Rotigotine—Asthenia—Docetaxel—head and neck cancer	0.000909	0.00239	CcSEcCtD
Rotigotine—Pruritus—Docetaxel—head and neck cancer	0.000896	0.00235	CcSEcCtD
Rotigotine—Diarrhoea—Docetaxel—head and neck cancer	0.000867	0.00227	CcSEcCtD
Rotigotine—Dizziness—Docetaxel—head and neck cancer	0.000838	0.0022	CcSEcCtD
Rotigotine—Vomiting—Docetaxel—head and neck cancer	0.000806	0.00211	CcSEcCtD
Rotigotine—Rash—Docetaxel—head and neck cancer	0.000799	0.0021	CcSEcCtD
Rotigotine—Dermatitis—Docetaxel—head and neck cancer	0.000798	0.00209	CcSEcCtD
Rotigotine—Headache—Docetaxel—head and neck cancer	0.000794	0.00208	CcSEcCtD
Rotigotine—Nausea—Docetaxel—head and neck cancer	0.000753	0.00197	CcSEcCtD
Rotigotine—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	1.78e-05	0.00188	CbGpPWpGaD
Rotigotine—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	1.75e-05	0.00185	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	1.73e-05	0.00182	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—KISS1—head and neck cancer	1.71e-05	0.00181	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—KISS1—head and neck cancer	1.69e-05	0.00178	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—TP53—head and neck cancer	1.66e-05	0.00174	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—PTEN—head and neck cancer	1.65e-05	0.00174	CbGpPWpGaD
Rotigotine—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	1.63e-05	0.00172	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—GRP—head and neck cancer	1.57e-05	0.00165	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—UROD—head and neck cancer	1.56e-05	0.00165	CbGpPWpGaD
Rotigotine—ADRA2B—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	1.54e-05	0.00162	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—KISS1—head and neck cancer	1.53e-05	0.00161	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—STAT6—head and neck cancer	1.52e-05	0.0016	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—TP53—head and neck cancer	1.49e-05	0.00157	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—KISS1—head and neck cancer	1.47e-05	0.00155	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—TP53—head and neck cancer	1.47e-05	0.00155	CbGpPWpGaD
Rotigotine—ADRA2B—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	1.47e-05	0.00154	CbGpPWpGaD
Rotigotine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	1.45e-05	0.00153	CbGpPWpGaD
Rotigotine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	1.43e-05	0.00151	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—GRP—head and neck cancer	1.41e-05	0.00149	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—GRP—head and neck cancer	1.39e-05	0.00147	CbGpPWpGaD
Rotigotine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	1.37e-05	0.00145	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—STAT6—head and neck cancer	1.37e-05	0.00144	CbGpPWpGaD
Rotigotine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.35e-05	0.00143	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—STAT6—head and neck cancer	1.35e-05	0.00142	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—YAP1—head and neck cancer	1.35e-05	0.00142	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KISS1—head and neck cancer	1.29e-05	0.00136	CbGpPWpGaD
Rotigotine—ADRA2B—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	1.27e-05	0.00134	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—GRP—head and neck cancer	1.26e-05	0.00132	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—STAT6—head and neck cancer	1.22e-05	0.00129	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.21e-05	0.00128	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—GRP—head and neck cancer	1.21e-05	0.00128	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—YAP1—head and neck cancer	1.21e-05	0.00128	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—UROD—head and neck cancer	1.21e-05	0.00127	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—YAP1—head and neck cancer	1.2e-05	0.00126	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—STAT6—head and neck cancer	1.18e-05	0.00124	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—TP53—head and neck cancer	1.12e-05	0.00119	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—YAP1—head and neck cancer	1.08e-05	0.00114	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—GRP—head and neck cancer	1.06e-05	0.00112	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—IL2—head and neck cancer	1.05e-05	0.00111	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—YAP1—head and neck cancer	1.04e-05	0.0011	CbGpPWpGaD
Rotigotine—ADRA2B—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	1.04e-05	0.00109	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—STAT6—head and neck cancer	1.03e-05	0.00109	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—IL2—head and neck cancer	9.88e-06	0.00104	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—IL2—head and neck cancer	9.58e-06	0.00101	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—YAP1—head and neck cancer	9.15e-06	0.000964	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—VEGFA—head and neck cancer	8.39e-06	0.000885	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—NOTCH1—head and neck cancer	8.22e-06	0.000866	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—MAPK3—head and neck cancer	7.94e-06	0.000837	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—IL2—head and neck cancer	7.78e-06	0.00082	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—MAPK3—head and neck cancer	7.7e-06	0.000811	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—NAT2—head and neck cancer	7.67e-06	0.000808	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—MAPK1—head and neck cancer	7.55e-06	0.000796	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—MAPK1—head and neck cancer	7.32e-06	0.000772	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—EGFR—head and neck cancer	7.32e-06	0.000772	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—IL2—head and neck cancer	7.07e-06	0.000745	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—IL2—head and neck cancer	7.01e-06	0.000738	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—PIK3CA—head and neck cancer	7e-06	0.000738	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—IL2—head and neck cancer	6.91e-06	0.000729	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.9e-06	0.000727	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.83e-06	0.00072	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—DPYD—head and neck cancer	6.73e-06	0.000709	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—PIK3CA—head and neck cancer	6.56e-06	0.000691	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NAT2—head and neck cancer	6.5e-06	0.000685	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—YAP1—head and neck cancer	6.38e-06	0.000673	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—IL2—head and neck cancer	6.36e-06	0.000671	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—PIK3CA—head and neck cancer	6.36e-06	0.00067	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—TP53—head and neck cancer	6.34e-06	0.000668	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—IL2—head and neck cancer	6.28e-06	0.000662	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—IL2—head and neck cancer	6.24e-06	0.000658	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NOTCH1—head and neck cancer	6.07e-06	0.000639	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—HRAS—head and neck cancer	6.06e-06	0.000639	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—IL2—head and neck cancer	6.02e-06	0.000635	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—HRAS—head and neck cancer	5.88e-06	0.00062	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—AKT1—head and neck cancer	5.72e-06	0.000603	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—DPYD—head and neck cancer	5.7e-06	0.000601	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—MAPK3—head and neck cancer	5.68e-06	0.000599	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—IL2—head and neck cancer	5.67e-06	0.000597	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IL2—head and neck cancer	5.66e-06	0.000596	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CCND1—head and neck cancer	5.51e-06	0.000581	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—IL2—head and neck cancer	5.47e-06	0.000577	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NOTCH1—head and neck cancer	5.46e-06	0.000576	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—YAP1—head and neck cancer	5.41e-06	0.00057	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—MAPK1—head and neck cancer	5.41e-06	0.00057	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—EGFR—head and neck cancer	5.41e-06	0.00057	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NOTCH1—head and neck cancer	5.39e-06	0.000568	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—AKT1—head and neck cancer	5.36e-06	0.000564	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—PTEN—head and neck cancer	5.32e-06	0.000561	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—IL2—head and neck cancer	5.29e-06	0.000558	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—AKT1—head and neck cancer	5.19e-06	0.000547	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—PIK3CA—head and neck cancer	5.17e-06	0.000544	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—MAPK3—head and neck cancer	5.12e-06	0.000539	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—MAPK3—head and neck cancer	5.05e-06	0.000532	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NAT2—head and neck cancer	5.02e-06	0.000529	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—MAPK1—head and neck cancer	4.87e-06	0.000513	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—EGFR—head and neck cancer	4.87e-06	0.000513	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NOTCH1—head and neck cancer	4.87e-06	0.000513	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—VEGFA—head and neck cancer	4.81e-06	0.000507	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—IL2—head and neck cancer	4.8e-06	0.000506	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—MAPK1—head and neck cancer	4.8e-06	0.000506	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—EGFR—head and neck cancer	4.8e-06	0.000506	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—STAT3—head and neck cancer	4.76e-06	0.000502	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NOTCH1—head and neck cancer	4.7e-06	0.000495	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—PIK3CA—head and neck cancer	4.69e-06	0.000494	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—PIK3CA—head and neck cancer	4.65e-06	0.00049	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—PIK3CA—head and neck cancer	4.59e-06	0.000484	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—MAPK3—head and neck cancer	4.56e-06	0.00048	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MAPK3—head and neck cancer	4.55e-06	0.000479	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—MAPK3—head and neck cancer	4.4e-06	0.000464	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—DPYD—head and neck cancer	4.4e-06	0.000463	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—HRAS—head and neck cancer	4.34e-06	0.000457	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—MAPK1—head and neck cancer	4.34e-06	0.000457	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—EGFR—head and neck cancer	4.33e-06	0.000457	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MAPK1—head and neck cancer	4.33e-06	0.000456	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—EGFR—head and neck cancer	4.33e-06	0.000456	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—PIK3CA—head and neck cancer	4.22e-06	0.000445	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—AKT1—head and neck cancer	4.22e-06	0.000445	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—MAPK1—head and neck cancer	4.19e-06	0.000441	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—EGFR—head and neck cancer	4.18e-06	0.000441	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL2—head and neck cancer	4.17e-06	0.00044	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—YAP1—head and neck cancer	4.17e-06	0.00044	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—PIK3CA—head and neck cancer	4.17e-06	0.000439	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—PIK3CA—head and neck cancer	4.14e-06	0.000437	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NOTCH1—head and neck cancer	4.12e-06	0.000435	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CCND1—head and neck cancer	4.07e-06	0.000429	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.06e-06	0.000428	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—PIK3CA—head and neck cancer	4e-06	0.000421	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PTEN—head and neck cancer	3.93e-06	0.000414	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—HRAS—head and neck cancer	3.91e-06	0.000412	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—MAPK3—head and neck cancer	3.86e-06	0.000407	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—HRAS—head and neck cancer	3.86e-06	0.000406	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—TYMS—head and neck cancer	3.83e-06	0.000404	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—AKT1—head and neck cancer	3.83e-06	0.000404	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—AKT1—head and neck cancer	3.8e-06	0.0004	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTM1—head and neck cancer	3.79e-06	0.000399	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—PIK3CA—head and neck cancer	3.76e-06	0.000397	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL2—head and neck cancer	3.76e-06	0.000396	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—PIK3CA—head and neck cancer	3.75e-06	0.000396	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—AKT1—head and neck cancer	3.75e-06	0.000395	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL2—head and neck cancer	3.71e-06	0.000391	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—MAPK1—head and neck cancer	3.67e-06	0.000387	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—EGFR—head and neck cancer	3.67e-06	0.000387	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCND1—head and neck cancer	3.66e-06	0.000386	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TP53—head and neck cancer	3.63e-06	0.000383	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—PIK3CA—head and neck cancer	3.63e-06	0.000383	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GPX1—head and neck cancer	3.63e-06	0.000382	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCND1—head and neck cancer	3.62e-06	0.000381	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	3.59e-06	0.000379	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—VEGFA—head and neck cancer	3.55e-06	0.000374	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.54e-06	0.000373	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PTEN—head and neck cancer	3.54e-06	0.000373	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—STAT3—head and neck cancer	3.51e-06	0.00037	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—PIK3CA—head and neck cancer	3.51e-06	0.00037	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PTEN—head and neck cancer	3.49e-06	0.000368	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—HRAS—head and neck cancer	3.48e-06	0.000367	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HRAS—head and neck cancer	3.47e-06	0.000366	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—AKT1—head and neck cancer	3.45e-06	0.000364	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—AKT1—head and neck cancer	3.4e-06	0.000359	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—AKT1—head and neck cancer	3.38e-06	0.000357	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—HRAS—head and neck cancer	3.36e-06	0.000354	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MAPK3—head and neck cancer	3.36e-06	0.000354	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL2—head and neck cancer	3.35e-06	0.000353	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—AKT1—head and neck cancer	3.27e-06	0.000344	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCND1—head and neck cancer	3.26e-06	0.000344	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—TYMS—head and neck cancer	3.25e-06	0.000342	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL2—head and neck cancer	3.23e-06	0.000341	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTM1—head and neck cancer	3.21e-06	0.000338	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—VEGFA—head and neck cancer	3.19e-06	0.000337	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MAPK1—head and neck cancer	3.19e-06	0.000337	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EGFR—head and neck cancer	3.19e-06	0.000337	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—PIK3CA—head and neck cancer	3.19e-06	0.000336	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—STAT3—head and neck cancer	3.16e-06	0.000333	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—VEGFA—head and neck cancer	3.15e-06	0.000332	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCND1—head and neck cancer	3.15e-06	0.000332	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PTEN—head and neck cancer	3.15e-06	0.000332	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—STAT3—head and neck cancer	3.12e-06	0.000329	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GPX1—head and neck cancer	3.07e-06	0.000324	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—AKT1—head and neck cancer	3.07e-06	0.000324	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—AKT1—head and neck cancer	3.07e-06	0.000323	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	3.04e-06	0.000321	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PTEN—head and neck cancer	3.04e-06	0.000321	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MAPK3—head and neck cancer	3.02e-06	0.000318	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MAPK3—head and neck cancer	2.98e-06	0.000314	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—AKT1—head and neck cancer	2.97e-06	0.000313	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—HRAS—head and neck cancer	2.95e-06	0.000311	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MAPK1—head and neck cancer	2.88e-06	0.000303	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EGFR—head and neck cancer	2.87e-06	0.000303	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	2.87e-06	0.000302	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—VEGFA—head and neck cancer	2.85e-06	0.0003	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL2—head and neck cancer	2.84e-06	0.000299	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MAPK1—head and neck cancer	2.84e-06	0.000299	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EGFR—head and neck cancer	2.84e-06	0.000299	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—STAT3—head and neck cancer	2.82e-06	0.000297	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PIK3CA—head and neck cancer	2.77e-06	0.000292	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCND1—head and neck cancer	2.77e-06	0.000292	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—VEGFA—head and neck cancer	2.75e-06	0.000289	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—STAT3—head and neck cancer	2.72e-06	0.000287	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MAPK3—head and neck cancer	2.69e-06	0.000284	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TP53—head and neck cancer	2.68e-06	0.000283	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PTEN—head and neck cancer	2.67e-06	0.000281	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—AKT1—head and neck cancer	2.6e-06	0.000275	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MAPK3—head and neck cancer	2.6e-06	0.000274	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HRAS—head and neck cancer	2.56e-06	0.00027	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MAPK1—head and neck cancer	2.56e-06	0.00027	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EGFR—head and neck cancer	2.56e-06	0.00027	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—TYMS—head and neck cancer	2.51e-06	0.000264	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.5e-06	0.000263	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PIK3CA—head and neck cancer	2.49e-06	0.000263	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.48e-06	0.000261	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MAPK1—head and neck cancer	2.47e-06	0.000261	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EGFR—head and neck cancer	2.47e-06	0.000261	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PIK3CA—head and neck cancer	2.46e-06	0.000259	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TP53—head and neck cancer	2.41e-06	0.000254	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—VEGFA—head and neck cancer	2.41e-06	0.000254	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—STAT3—head and neck cancer	2.39e-06	0.000252	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TP53—head and neck cancer	2.38e-06	0.000251	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GPX1—head and neck cancer	2.37e-06	0.00025	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.35e-06	0.000247	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HRAS—head and neck cancer	2.31e-06	0.000243	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAPK3—head and neck cancer	2.28e-06	0.00024	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HRAS—head and neck cancer	2.28e-06	0.00024	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—AKT1—head and neck cancer	2.26e-06	0.000239	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CA—head and neck cancer	2.22e-06	0.000234	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAPK1—head and neck cancer	2.17e-06	0.000229	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EGFR—head and neck cancer	2.17e-06	0.000229	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TP53—head and neck cancer	2.15e-06	0.000227	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CA—head and neck cancer	2.15e-06	0.000226	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTGS2—head and neck cancer	2.14e-06	0.000225	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TP53—head and neck cancer	2.08e-06	0.000219	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HRAS—head and neck cancer	2.06e-06	0.000217	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AKT1—head and neck cancer	2.04e-06	0.000215	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—AKT1—head and neck cancer	2.01e-06	0.000212	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HRAS—head and neck cancer	1.98e-06	0.000209	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	1.88e-06	0.000199	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTEN—head and neck cancer	1.86e-06	0.000196	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TP53—head and neck cancer	1.82e-06	0.000192	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AKT1—head and neck cancer	1.82e-06	0.000191	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.81e-06	0.000191	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AKT1—head and neck cancer	1.75e-06	0.000185	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HRAS—head and neck cancer	1.74e-06	0.000184	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTEN—head and neck cancer	1.58e-06	0.000166	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKT1—head and neck cancer	1.54e-06	0.000162	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.4e-06	0.000147	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.31e-06	0.000138	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTEN—head and neck cancer	1.22e-06	0.000128	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.11e-06	0.000117	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—AKT1—head and neck cancer	1.07e-06	0.000113	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—AKT1—head and neck cancer	9.09e-07	9.58e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	8.59e-07	9.05e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AKT1—head and neck cancer	7.02e-07	7.4e-05	CbGpPWpGaD
